Skip to main content
Log in

IBS economic burden substantial for US Medicaid

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Rights and permissions

Reprints and permissions

About this article

Cite this article

IBS economic burden substantial for US Medicaid. Pharmacoecon. Outcomes News 442, 8 (2003). https://doi.org/10.1007/BF03277168

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03277168

Keywords

Navigation